Background: Semaglutide, a Glucagon-like peptide-1 (GLP-1) agonist, has become one of the most prescribed medications as a result of its beneficial cardiovascular profile and beneficial side effect of weight loss. There is a paucity in literature about its adverse effects. We aimed to conduct a meta-analysis of the severe adverse effects (SAE) of Semaglutide using [...]

Case Presentation: A 70-year-old female with coronary artery disease (s/p drug-eluting stent x 2 10 years ago), Type 2 Diabetes Mellitus, rheumatoid arthritis, Chronic Obstructive Pulmonary Disease, and remote history of bladder cancer presented to the emergency department with two weeks of nausea, jaundice, dark colored urine, loss of appetite, and clay-colored stool. The patient [...]